1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Attention Deficit Hyperactivity Disorder Market, By Medication
5.1 Introduction
5.2 Stimulant
5.2.1 Amphetamine
5.2.2 Dexmethylphenidate
5.2.3 Methylphenidate
5.2.4 Methylphenidate
5.2.5 Lisdexamfetamine dimesylate
5.3 Non Stimulant
5.3.1 Atomoxetine
5.3.2 Guanfacine
5.3.3 Atomoxetine
5.3.4 Clonidine
5.4 Other Medications
6 Global Attention Deficit Hyperactivity Disorder Market, By Psychotherapy
6.1 Introduction
6.2 Behaviour Therapy
6.3 Cognitive Behavioural Therapy
6.4 Family Therapy
6.5 Interpersonal Psychotherapy
6.6 Other Psychotherapies
7 Global Attention Deficit Hyperactivity Disorder Market, By Education Or Training
7.1 Introduction
7.2 Social Skills Training
7.3 Parent Management Training
7.4 School-Based Interventions
7.5 Other Education Or Trainings
8 Global Attention Deficit Hyperactivity Disorder Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacy
8.3 Hospital Pharmacy
8.4 Specialty Clinics
8.5 E-Commerce
8.6 Other Distribution Channel
9 Global Attention Deficit Hyperactivity Disorder Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Noven Pharmaceuticals, Inc.
11.2 Takeda Pharmaceutical Company Limited
11.3 Neos Therapeutics, Inc.
11.4 Supernus Pharmaceuticals
11.5 Novartis AG
11.6 Johnson & Johnson
11.7 Lilly, Pfizer Inc.
11.8 Alcobra Ltd.
11.9 Neurosigma, Inc
11.10 Hisamitsu Pharmaceutical Co.,Inc
11.11 KemPharm, Inc.
11.12 Curemark, LLC.
11.13 Mallinckrodt, UCB S.A.
11.14 Purdue Pharma L.P.
11.15 Actavis
List of Tables
Table 1 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 3 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 4 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 5 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 6 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 7 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 8 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 9 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 10 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 11 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 12 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 13 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 14 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 15 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 16 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 17 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 18 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 19 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 20 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 21 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 22 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 23 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 24 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 25 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 26 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 27 Global Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 28 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 29 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 30 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 31 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 32 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 33 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 34 Global Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 35 Global Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 36 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 37 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 38 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 39 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 40 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 41 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 42 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 43 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 44 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 45 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 46 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 47 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 48 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 49 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 50 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 51 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 52 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 53 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 54 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 55 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 56 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 57 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 58 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 59 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 60 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 61 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 62 North America Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 63 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 64 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 65 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 66 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 67 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 68 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 69 North America Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 70 North America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 71 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 72 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 73 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 74 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 75 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 76 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 77 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 78 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 79 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 80 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 81 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 82 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 83 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 84 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 85 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 86 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 87 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 88 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 89 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 90 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 91 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 92 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 93 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 94 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 95 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 96 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 97 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 98 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 99 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 100 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 101 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 102 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 103 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 104 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 105 Europe Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 106 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 107 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 108 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 109 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 110 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 111 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 112 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 113 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 114 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 115 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 116 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 117 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 118 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 119 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 120 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 121 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 122 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 123 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 124 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 125 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 126 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 127 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 128 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 129 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 130 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 131 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 132 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 133 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 134 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 135 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 136 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 137 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 138 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 139 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 140 Asia Pacific Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 141 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 142 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 143 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 144 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 145 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 146 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 147 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 148 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 149 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 150 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 151 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 152 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 153 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 154 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 155 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 156 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 157 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 158 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 159 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 160 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 161 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 162 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 163 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 164 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 165 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 166 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 167 South America Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 168 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 169 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 170 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 171 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 172 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 173 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 174 South America Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 175 South America Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
Table 176 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Country (2020-2028) ($MN)
Table 177 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Medication (2020-2028) ($MN)
Table 178 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 179 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Stimulant (2020-2028) ($MN)
Table 180 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Amphetamine (2020-2028) ($MN)
Table 181 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Dexmethylphenidate (2020-2028) ($MN)
Table 182 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 183 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Methylphenidate (2020-2028) ($MN)
Table 184 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Lisdexamfetamine dimesylate (2020-2028) ($MN)
Table 185 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Non Stimulant (2020-2028) ($MN)
Table 186 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 187 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Guanfacine (2020-2028) ($MN)
Table 188 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Atomoxetine (2020-2028) ($MN)
Table 189 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Clonidine (2020-2028) ($MN)
Table 190 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Medications (2020-2028) ($MN)
Table 191 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Psychotherapy (2020-2028) ($MN)
Table 192 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 193 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Behaviour Therapy (2020-2028) ($MN)
Table 194 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Cognitive Behavioral Therapy (2020-2028) ($MN)
Table 195 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Family Therapy (2020-2028) ($MN)
Table 196 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Interpersonal Psychotherapy (2020-2028) ($MN)
Table 197 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Psychotherapies (2020-2028) ($MN)
Table 198 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Education Or Training (2020-2028) ($MN)
Table 199 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 200 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Social Skills Training (2020-2028) ($MN)
Table 201 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Parent Management Training (2020-2028) ($MN)
Table 202 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By School-Based Interventions (2020-2028) ($MN)
Table 203 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Education Or Trainings (2020-2028) ($MN)
Table 204 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Distribution Channel (2020-2028) ($MN)
Table 205 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Introduction (2020-2028) ($MN)
Table 206 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 207 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 208 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Specialty Clinics (2020-2028) ($MN)
Table 209 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By E-Commerce (2020-2028) ($MN)
Table 210 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Outlook, By Other Distribution Channel (2020-2028) ($MN)
| ※参考情報 注意欠如・多動症（ADHD）とは、主に注意力の欠如、多動性、衝動性という三つの主な症状を持つ神経発達障害の一つです。この障害は、子供から大人まで影響を及ぼし、社会生活や学業、職業活動においてさまざまな困難を引き起こすことがあります。ADHDは遺伝的要因や環境要因が相互に作用して発症することが知られています。 ADHDには主に三つのタイプがあります。一つ目は「注意欠如優勢型」であり、主に注意力の欠如が目立つ状態です。このタイプでは、集中力が続かない、タスクを最後までやり遂げられない、忘れ物が多いといった症状が見られます。二つ目は「多動・衝動優勢型」で、こちらは多動性や衝動的な行動が目立ちます。座っていられない、話を遮る、思いついたことをすぐに行動に移してしまうといった症状が特徴です。三つ目は「混合型」で、注意欠如と多動・衝動の両方の症状が見られるタイプです。 ADHDの診断は、専門的な評価が必要です。心理士や精神科医などの専門家が、行動観察や親子面接、標準化された質問票を用いて診断を行います。診断基準には、国際的な基準であるDSM-5（精神障害の診断と統計マニュアル）やICD-10（国際疾病分類）などが使用されます。 ADHDの治療には、薬物療法や心理社会的療法が使われます。薬物療法では、主に中枢神経刺激薬や非刺激薬が使用され、これにより注意力や集中力の改善が期待できます。具体的には、メチルフェニデートやアンフェタミン類の薬剤が一般的に処方されます。一方、心理社会的療法には行動療法や認知行動療法が含まれ、自己管理のスキルを学ぶことや社会的スキルを磨くことが目指されます。 ADHDは幼少期に発症することが多いですが、成人になっても症状が続く場合があります。成人期にADHDを持つ人は、仕事や家庭生活においてのストレスや困難に直面することが多く、適切な支援が求められます。また、ADHDは往々にして他の精神障害、例えば不安障害やうつ病と併発することもあります。これらの関連障害に対する治療も重要です。 最近では、ADHDに関連する研究が進んでおり、脳の機能や神経伝達物質の関与についての理解が深まっています。特に、ドーパミンやノルアドレナリンといった神経伝達物質がADHDの症状に大きく関与していることが分かってきました。この知見は、より効果的な治療法の開発につながる体験として期待されています。 また、ADHDの特性を活かした教育方法や職場環境の工夫も進められています。個別指導や特別支援教育によって、ADHDの子供たちが適切なサポートを受けることで、学業成績や社会性を向上させることが可能です。職場においては、フレキシブルな働き方やタスク管理ツールの利用がADHDを持つ成人にとって有効であるとされています。 ADHDに関する情報は、近年ますます多くの関心を集めています。正しい理解と適切な対応がなされることで、ADHDの人々が持つ特有の才能や魅力を活かし、充実した生活を送ることができるようになることが望まれています。理解促進のために、教育機関や企業においてもADHDに関する研修が行われるようになり、社会全体がこの障害について知識を深めていくことが重要です。以上のように、ADHDに関する理解と支援は多岐にわたりますが、まだまだ改善の余地があるため、引き続きの努力が求められます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
